Discover
ZBH
Zimmer Biomet Holdings, Inc.
84.17
300 x undefined
100 x undefined
bid
ask
-
1.92
2.23%
200 @ 04:00 PM
85.50 +1.33 (1.58%)
| Ytd | -6.39% | |
| 1y | -9.98% |
84.07
day range
87.20
79.12
52 week range
108.29
| Open | 86.70 | Prev Close | 86.09 | Low | 84.07 | High | 87.20 | Mkt Cap | 16.28B |
| Vol | 2.54M | Avg Vol | 2.39M | EPS | 3.86 | P/E | 21.81 | Forward P/E | 9.36 |
| Beta | 0.47 | Short Ratio | 5.49 | Inst. Own | 106.40% | Dividend | 0.96 | Div Yield | 1.12 |
| Ex Div Date | 06-25 | Earning | 04-28 | 50-d Avg | 86.12 | 200-d Avg | 91.90 | 1yr Est | 98.70 |
ZBH News
zacks.com
Pacira to Divest iovera Business to Zimmer Biomet in Up To $140M Deal
PCRX is set to sell its iovera franchise to ZBH in a deal worth up to $140M as it sharpens focus on
benzinga.com
AI Chips Power Wall Street Higher, Dow Eyes Records: Stock Market Today
Tech and semis lead the S&P 500 and Nasdaq higher into quarter-end
benzinga.com
Pacira BioSciences Divests Iovera To Zimmer Biomet For Up To $140M
Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative